Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
STEM-02. SYNGN: A NOVEL EPIGENETIC PLATFORM FOR PATIENT-SPECIFIC DRUG-MATCHING IN GLIOBLASTOMA
QMRO Home
Blizard Institute
Centre for Genomics and Child Health
STEM-02. SYNGN: A NOVEL EPIGENETIC PLATFORM FOR PATIENT-SPECIFIC DRUG-MATCHING IN GLIOBLASTOMA
QMRO Home
Blizard Institute
Centre for Genomics and Child Health
STEM-02. SYNGN: A NOVEL EPIGENETIC PLATFORM FOR PATIENT-SPECIFIC DRUG-MATCHING IN GLIOBLASTOMA
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
STEM-02. SYNGN: A NOVEL EPIGENETIC PLATFORM FOR PATIENT-SPECIFIC DRUG-MATCHING IN GLIOBLASTOMA
Volume
25
Pagination
v33 - v33
Publisher
Oxford University Press (OUP)
DOI
10.1093/neuonc/noad179.0129
Journal
Neuro-Oncology
Issue
Supplement_5
ISSN
1522-8517
Metadata
Show full item record
Authors
Vinel, C; Boot, J; Zabet, R; Brandner, S; Marino, S
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/93526
Collections
Centre for Genomics and Child Health
[826]